Drug delivery as a sustainable avenue to future therapies

被引:5
|
作者
Fuhrmann, Gregor [1 ]
机构
[1] Friedrich Alexander Univ Erlangen Nurnberg, Dept Biol, Pharmaceut Biol, Staudtstr 5, D-91058 Erlangen, Germany
关键词
Sustainable pharmacy; Infection research; Extracellular vesicles; Natural products; Education for sustainable development; Sustainable development goals; Academic publishing; FETAL BOVINE SERUM; EXTRACELLULAR VESICLES; MEMBRANE-VESICLES; EXOSOMES; SYSTEMS; NANOPARTICLES; DISCOVERY; BACTERIA;
D O I
10.1016/j.jconrel.2023.01.045
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Climate change and the need for sustainable, technological developments are the greatest challenges facing humanity in the coming decades. To address these issues, in 2015 the United Nations have established 17 Sustainable Development Goals. Anthropogenic climate change will not only affect everyone personally in the coming years, it will also reinforce the need to become more sustainable within drug delivery research. In 2021, I was appointed professor for pharmaceutical biology at the Friedrich-Alexander-University Erlangen-Nurnberg. Our research is at the interface between developing biogenic therapies and understanding of bacterial infections. In this contribution to the Orations - New Horizons of the Journal of Controlled Release, I would like to underline the need for future sustainable approaches in our research area, by highlighting selected examples from the fields of infection research, natural product characterisation and extracellular vesicles. My aim is to put into perspective current issues for these research topics, but also encourage our current student-training framework to contribute to education for sustainable development. This contribution is a personal statement to increase the overall awareness for sustainability challenges in drug delivery and beyond.
引用
下载
收藏
页码:746 / 754
页数:9
相关论文
共 50 条
  • [31] Therapies Based on Nanoparticles for Eye Drug Delivery
    Alejandra Meza-Rios
    Jose Navarro-Partida
    Juan Armendariz-Borunda
    Arturo Santos
    Ophthalmology and Therapy, 2020, 9 : 1 - 14
  • [32] New frontiers in intravesical therapies and drug delivery
    Giannantoni, Antonella
    Di Stasi, Savino M.
    Chancellor, Michael B.
    Costantini, Elisabetta
    Porena, Massimo
    EUROPEAN UROLOGY, 2006, 50 (06) : 1183 - 1193
  • [33] Current and future drug therapies for alcohol dependence
    Rosenthal, Richard N.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2006, 26 : S20 - S29
  • [34] New and future drug therapies for rheumatoid arthritis
    Simon, LS
    Yocum, D
    RHEUMATOLOGY, 2000, 39 : 36 - 42
  • [35] The need for collaboration in the future delivery of improved therapies for patients
    Haigh, Jeremy
    HEALTH POLICY AND TECHNOLOGY, 2014, 3 (04) : 219 - 222
  • [36] Microemulsions in future drug delivery vehicles
    Hedstrom, Gun
    Backlund, Sune
    Eriksson, Folke
    Karlsson, Stefan
    Kemia-Kemi/Finnish Chemical Journal, 26 (03): : 218 - 221
  • [37] Drug delivery: What the future holds
    Lambert, William J.
    BIOPHARM INTERNATIONAL, 2007, 20 (08) : 32 - +
  • [38] Controlled drug delivery: Present and future
    Park, Kinam
    Mrsny, Randall J.
    2000, Oxford University Press (752):
  • [39] Future challenges for drug delivery research
    Leiden/Amsterdam Ctr. for Drug Res., Leiden University, P.O. Box 9502, 2300 RA Leiden, Netherlands
    Adv. Drug Deliv. Rev., 3 (265-268):
  • [40] Drug delivery in biotechnology:: present and future
    Orive, G
    Hernández, RM
    Gascón, AR
    Domínguez-Gil, A
    Pedraz, JL
    CURRENT OPINION IN BIOTECHNOLOGY, 2003, 14 (06) : 659 - 664